Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Source Bioscience PLC announces acquisition of Inverclyde Biologicals Ltd

Tuesday, 30 Apr 2013 02:00am EDT 

Source Bioscience PLC announced the acquisition of the entire issued share capital of Inverclyde Biologicals Ltd, Motherwell, Scotland for a total consideration of GBP1.6 million payable in cash. Inverclyde is a manufacturer of diagnostic kitsand blood group serology reagents. 

Company Quote

0.25 +2.00%
8:39am EDT